SAB Biotherapeutics (SABS) Current Deferred Revenue (2020 - 2024)
SAB Biotherapeutics' Current Deferred Revenue came in at $114,698 for Q3 2024, down 93.0% from $1.63 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Current Deferred Revenue (2020 - 2024) Analysis & Trends
At the end of FY2023, SAB Biotherapeutics' Current Deferred Revenue was $1.32 million.
- Current Deferred Revenue carries a three-year compound annual growth rate of 136.5% (FY2020 to FY2023).
- Going back by year, Current Deferred Revenue was $100,000 in FY2021 (unchanged) and $100,000 in FY2020.
- The five-year range for quarterly Current Deferred Revenue is $100,000 (Q4 2020) to $2.94 million (Q1 2023).
- Year-over-year, Current Deferred Revenue has declined for three consecutive quarters.
- Business Quant data shows SABS's Current Deferred Revenue at $114,698 (Q2 2024), $377,835 (Q1 2024) and $1.32 million (Q4 2023) in the three quarters before Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | SAB Biotherapeutics | 279.79 Mn | -130.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 114,698.00 |
| Jun 30, 2024 | 114,698.00 |
| Mar 31, 2024 | 377,835.00 |
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 2.89 Mn |
| Mar 31, 2023 | 2.94 Mn |
| Sep 30, 2022 | -100,000.00 |
| Jun 30, 2022 | -100,000.00 |
| Mar 31, 2022 | -100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Dec 31, 2020 | 100,000.00 |
API Access
SAB Biotherapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();